Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Contents - page 186
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial70
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study67
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France60
Editorial board49
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department44
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report37
Contents36
Association between adipose deposition and mortality among adults without major cardiovascular risk factors35
Editorial board35
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood33
Body weight trends in Individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps32
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes31
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”31
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients31
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis30
Concise review of lipidomics in nonalcoholic fatty liver disease30
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202129
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review27
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes27
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202026
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes26
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes26
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study25
Sommaire25
Contents25
Type B insulin resistance syndrome: A case report25
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability24
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study23
1-h post-load plasma glucose for detecting early stages of prediabetes22
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-201821
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”20
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY320
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes20
Averaged glycaemic variability or by average: More than a simple question of wording19
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [Diabetes Metab 2021 Apr 13; 101251]19
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications19
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT18
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study18
Glucose management indicator: Do we need device-specific equations?18
Editorial board17
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study17
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin17
Contents - Page 116
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease15
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study15
Diabetes prevalence, awareness, and control in the United States, 2017-202315
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction15
Editorial board15
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations14
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies14
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation14
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention14
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach14
Transitions in metabolic health status over time and risk of heart failure: A prospective study14
Contents - page 113
Glucagon like peptide-1 receptor agonists in type 1 diabetes13
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes13
Contents13
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus13
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease12
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy11
Contents11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design11
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance11
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer11
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults10
Editorial board10
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals10
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report10
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders10
Diabetic ketoacidosis and mortality in COVID-19 infection10
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus9
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis9
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan9
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography9
Editorial board9
Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study9
Editorial board8
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION8
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study8
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus8
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists8
Editorial board8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease8
0.053957939147949